The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.
The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.
Read more about the lawsuit: Insulin makers accused of price-fixing scheme
More from our investigation:
In Other News
1
Two Xenia teachers placed on leave amid investigation over Charlie Kirk...
2
$6.9M log home, horse farm on market in Warren County: See photos
3
Classes to resume at Stebbins High School after unsubstantiated threat
4
Developer plans to build 97 luxury homes in Washington Twp.
5
State action to remove some voted members of STRS board paused for now
About the Author